Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2373

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;113:2373.)
© 2006 American Heart Association, Inc.

Issue Highlights


*    FOCAL PHARMACOLOGICAL MODULATION OF ATRIOVENTRICULAR NODAL CONDUCTION VIA IMPLANTABLE CATHETER: A NOVEL THERAPY FOR ATRIAL FIBRILLATION? by Sigg et al.
up arrowTop
*FOCAL PHARMACOLOGICAL MODULATION...
down arrowIMPLEMENTATION OF GUIDELINES...
down arrowSUPPRESSION OF ATHEROSCLEROTIC...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Medical treatment of atrial fibrillation using antiarrhythmic agents or ventricular rate control is challenging because of variable success and systemic side effects. In this issue of Circulation, Sigg and colleagues describe a local catheter-based delivery system for administration of drugs to alter atrioventricular nodal conduction. They implanted a catheter at the atrioventricular nodal region for local infusion of acetylcholine and demonstrated proof-of-principle in an acute canine model. Regulation of atrioventricular nodal refractoriness and conduction properties was achieved using low-dose local drug delivery without systemic actions. It is conceivable that focal drug therapy may eventually be combined with an implantable pacemaker-type device using a closed-loop feedback system to chronically modulate ventricular rate control during atrial arrhythmias. See p 2383.


*    IMPLEMENTATION OF GUIDELINES IMPROVES STANDARD OF CARE: THE VIENNESE REGISTRY ON REPERFUSION STRATEGIES IN ST-ELEVATION MYOCARDIAL INFARCTION (VIENNA STEMI REGISTRY), by Kalla et al.
up arrowTop
up arrowFOCAL PHARMACOLOGICAL MODULATION...
*IMPLEMENTATION OF GUIDELINES...
down arrowSUPPRESSION OF ATHEROSCLEROTIC...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
For the past 25 years, various guidelines for the treatment of acute ST-segment–elevation myocardial infarction (STEMI) have consistently emphasized the importance of time to reperfusion over the importance of the reperfusion method itself. Once emergency departments had successfully optimized speed to diagnosis and reperfusion, ie achieving a door-to-needle or door-to-balloon time of cutaneous coronary intervention (PPCI) became the preferred therapy over intravenous thrombolysis because of its lower stroke rate, value of coronary anatomy definition, and more definitive treatment of the culprit lesion. However, application of a PPCI solution for STEMI in most communities is strategically difficult, and the prioritization of a PPCI strategy over a time-to-reperfusion strategy has resulted in substantial delays with important clinical consequences. Kalla and colleagues describe the implementation of an ambulance triage system that coordinated the management of STEMI at 5 hospital emergency systems servicing Vienna, Austria. An algorithm was deployed that utilized changing diurnal and geographic PPCI resources to achieve AHA/ACC guideline reperfusion goals within 2 hours as the first priority and PPCI, whenever possible, as the second priority. Other subalgorithms were also employed. The study describes the execution of the algorithms for the study cohort and the breakdown of results by timing, reperfusion therapy, patient characteristics, and mortality outcomes. The study’s main value is the health service perspective of this city’s imaginative implementation of society guideline goals in a realistic environment in which limited resources exist. Although there is an uncontrolled comparison of results after policy implementation, with earlier benchmarks suggesting lower mortality and higher rates of reperfusion therapy, the citizens of Vienna are clearly the beneficiaries of this program, which aims for guideline-driven quality improvement. See p 2398.


*    SUPPRESSION OF ATHEROSCLEROTIC PLAQUE PROGRESSION AND INSTABILITY BY TISSUE INHIBITOR OF METALLOPROTEINASE-2: INVOLVEMENT OF MACROPHAGE MIGRATION AND APOPTOSIS, by Johnson et al.
up arrowTop
up arrowFOCAL PHARMACOLOGICAL MODULATION...
up arrowIMPLEMENTATION OF GUIDELINES...
*SUPPRESSION OF ATHEROSCLEROTIC...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Although extracellular matrix degradation by vascular cell proteases has been hypothesized as a mechanism of atherosclerotic plaque progression and rupture, direct experimental evidence is scant. In this issue of Circulation, Johnson et al investigate whether adenoviral overexpression of tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 would attenuate plaque growth and instability in brachiocephalic artery plaques of apolipoprotein E–deficient mice. Over-expression of TIMP-2, but not of TIMP-1, inhibited plaque development and destabilization. Modification of adenoviral vectors was required to maintain these favorable effects longer term. This study provides a proof-of-principle approach to modulate features of plaque stability. See p 2435.

Visit http://circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowFOCAL PHARMACOLOGICAL MODULATION...
up arrowIMPLEMENTATION OF GUIDELINES...
up arrowSUPPRESSION OF ATHEROSCLEROTIC...
*Images in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
A Swelling of the Right Neck and Sudden Death. See p e768.


Figure 13656
View larger version (62K):
[in this window]
[in a new window]
 

Methemoglobinemia as a Rare Complication During a Transesophageal Echocardiogram. See p e770.

Multimodality Imaging of Cardiac Sarcoidosis Before and After Steroid Therapy. See p e771.


*    Book Review
up arrowTop
up arrowFOCAL PHARMACOLOGICAL MODULATION...
up arrowIMPLEMENTATION OF GUIDELINES...
up arrowSUPPRESSION OF ATHEROSCLEROTIC...
up arrowImages in Cardiovascular...
*Book Review
down arrowCorrespondence
 
Cardiac Remodeling: Mechanism and Treatment. See p e774.


*    Correspondence
up arrowTop
up arrowFOCAL PHARMACOLOGICAL MODULATION...
up arrowIMPLEMENTATION OF GUIDELINES...
up arrowSUPPRESSION OF ATHEROSCLEROTIC...
up arrowImages in Cardiovascular...
up arrowBook Review
*Correspondence
 
See p e775.


Related Articles:

A Swelling of the Right Neck and Sudden Death
Thomas Neumann, Anja Bornkessel, Stefan O.R. Pfleiderer, Gert Hein, Stefan Isenmann, Gunter Wolf, and Christoph Terborg
Circulation 2006 113: e768-e769. [Extract] [Full Text]

Methemoglobinemia as a Rare Complication During a Transesophageal Echocardiogram
Rami N. Khouzam
Circulation 2006 113: e770. [Extract] [Full Text]

Multimodality Imaging of Cardiac Sarcoidosis Before and After Steroid Therapy
Eiji Tadamura, Masaki Yamamuro, Shigeto Kubo, Shotaro Kanao, Ryohei Hosokawa, Takeshi Kimura, Toru Kita, and Kaori Togashi
Circulation 2006 113: e771-e773. [Extract] [Full Text]

Cardiac Remodeling: Mechanism and Treatment
Sidney Goldstein
Circulation 2006 113: e774. [Extract] [Full Text]

Letter Regarding Article by Khan et al, "Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis"
Fred S. Apple, Allan S. Jaffe, and Charles A. Herzog
Circulation 2006 113: e775. [Extract] [Full Text]

Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry)
Karim Kalla, Günter Christ, Ronald Karnik, Reinhard Malzer, Georg Norman, Herbert Prachar, Wolfgang Schreiber, Gerhard Unger, Helmut D. Glogar, Alfred Kaff, Anton N. Laggner, Gerald Maurer, Johannes Mlczoch, Joerg Slany, Heinrich S. Weber, Kurt Huber for the Vienna STEMI Registry Group
Circulation 2006 113: 2398-2405. [Abstract] [Full Text]

Focal Pharmacological Modulation of Atrioventricular Nodal Conduction via Implantable Catheter: A Novel Therapy for Atrial Fibrillation?
Daniel C. Sigg, Prasanga Hiniduma-Lokuge, James A. Coles, Jr, Phillip Falkner, Rebecca Rose, Jon F. Urban, and Michael R. Ujhelyi
Circulation 2006 113: 2383-2390. [Abstract] [Full Text]

Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis
Jason L. Johnson, Andrew H. Baker, Kazuhiro Oka, Lawrence Chan, Andrew C. Newby, Christopher L. Jackson, and Sarah J. George
Circulation 2006 113: 2435-2444. [Abstract] [Full Text]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles